US Stock MarketDetailed Quotes

PSTV Plus Therapeutics

Watchlist
  • 1.1700
  • -0.0201-1.69%
Close Jan 17 16:00 ET
  • 1.1700
  • 0.00000.00%
Post 19:59 ET
6.90MMarket Cap-0.49P/E (TTM)

Plus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
16.86%3.8M
148.12%3.7M
-30.14%3.3M
-32.42%13.32M
-30.76%3.86M
-36.18%3.25M
-70.90%1.49M
20.28%4.72M
58.64%19.71M
43.20%5.57M
Selling and administrative expenses
19.97%2.4M
14.50%2.2M
-1.43%2.21M
-16.55%8.54M
-33.70%2.38M
-10.08%2M
-15.95%1.92M
4.86%2.25M
49.39%10.24M
75.56%3.59M
-General and administrative expense
19.97%2.4M
14.50%2.2M
-1.43%2.21M
-16.55%8.54M
-33.70%2.38M
-10.08%2M
-15.95%1.92M
4.86%2.25M
49.39%10.24M
75.56%3.59M
Research and development costs
14.64%2.86M
95.28%2.77M
-7.38%2.76M
-0.08%9.69M
30.68%2.79M
-15.35%2.49M
-49.84%1.42M
67.11%2.98M
74.02%9.7M
15.63%2.14M
Other operating expenses
-17.42%-1.46M
31.01%-1.28M
-231.42%-1.68M
-2,093.30%-4.91M
-769.54%-1.31M
-1,598.63%-1.24M
---1.85M
---506K
---224K
---151K
Operating profit
-16.86%-3.8M
-148.12%-3.7M
30.14%-3.3M
32.42%-13.32M
30.76%-3.86M
36.18%-3.25M
70.90%-1.49M
-20.28%-4.72M
-58.64%-19.71M
-43.20%-5.57M
Net non-operating interest income expense
-40.63%19K
-43,912.50%-3.51M
145.78%38K
100.89%5K
155.81%48K
125.60%32K
104.94%8K
56.54%-83K
38.23%-564K
60.55%-86K
Non-operating interest income
-32.77%80K
-44.17%67K
41.18%72K
172.11%400K
50.68%110K
147.92%119K
531.58%120K
628.57%51K
673.68%147K
1,116.67%73K
Non-operating interest expense
-29.89%61K
3,089.29%3.57M
-74.63%34K
-44.44%395K
-61.01%62K
-49.71%87K
-38.12%112K
-32.32%134K
-23.71%711K
-29.02%159K
Other net income (expense)
906K
4.26M
101.67%1K
0
Gain on sale of security
--906K
--4.26M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
--1K
----
Income before tax
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
34.32%-13.32M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.81M
-51.32%-20.28M
-36.17%-5.66M
Income tax
Net income
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
34.32%-13.32M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.81M
-51.32%-20.28M
-36.17%-5.66M
Net income continuous Operations
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
34.32%-13.32M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.81M
-51.32%-20.28M
-36.17%-5.66M
Minority interest income
Net income attributable to the parent company
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
34.32%-13.32M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.81M
-51.32%-20.28M
-36.17%-5.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.72%-2.87M
-98.38%-2.94M
32.13%-3.26M
34.32%-13.32M
32.66%-3.81M
38.32%-3.22M
71.94%-1.48M
-16.74%-4.81M
-51.32%-20.28M
-36.17%-5.66M
Basic earnings per share
63.00%-0.37
23.73%-0.45
63.77%-0.75
63.39%-4.24
70.34%-0.7
64.91%-1
83.43%-0.59
27.37%-2.07
30.45%-11.58
41.73%-2.36
Diluted earnings per share
63.00%-0.37
-20.34%-0.71
63.77%-0.75
63.39%-4.24
70.34%-0.7
64.91%-1
83.43%-0.59
27.37%-2.07
30.45%-11.58
41.73%-2.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 16.86%3.8M148.12%3.7M-30.14%3.3M-32.42%13.32M-30.76%3.86M-36.18%3.25M-70.90%1.49M20.28%4.72M58.64%19.71M43.20%5.57M
Selling and administrative expenses 19.97%2.4M14.50%2.2M-1.43%2.21M-16.55%8.54M-33.70%2.38M-10.08%2M-15.95%1.92M4.86%2.25M49.39%10.24M75.56%3.59M
-General and administrative expense 19.97%2.4M14.50%2.2M-1.43%2.21M-16.55%8.54M-33.70%2.38M-10.08%2M-15.95%1.92M4.86%2.25M49.39%10.24M75.56%3.59M
Research and development costs 14.64%2.86M95.28%2.77M-7.38%2.76M-0.08%9.69M30.68%2.79M-15.35%2.49M-49.84%1.42M67.11%2.98M74.02%9.7M15.63%2.14M
Other operating expenses -17.42%-1.46M31.01%-1.28M-231.42%-1.68M-2,093.30%-4.91M-769.54%-1.31M-1,598.63%-1.24M---1.85M---506K---224K---151K
Operating profit -16.86%-3.8M-148.12%-3.7M30.14%-3.3M32.42%-13.32M30.76%-3.86M36.18%-3.25M70.90%-1.49M-20.28%-4.72M-58.64%-19.71M-43.20%-5.57M
Net non-operating interest income expense -40.63%19K-43,912.50%-3.51M145.78%38K100.89%5K155.81%48K125.60%32K104.94%8K56.54%-83K38.23%-564K60.55%-86K
Non-operating interest income -32.77%80K-44.17%67K41.18%72K172.11%400K50.68%110K147.92%119K531.58%120K628.57%51K673.68%147K1,116.67%73K
Non-operating interest expense -29.89%61K3,089.29%3.57M-74.63%34K-44.44%395K-61.01%62K-49.71%87K-38.12%112K-32.32%134K-23.71%711K-29.02%159K
Other net income (expense) 906K4.26M101.67%1K0
Gain on sale of security --906K--4.26M--------------------------------
Other non- operating income (expenses) ----------------------------------1K----
Income before tax 10.72%-2.87M-98.38%-2.94M32.13%-3.26M34.32%-13.32M32.66%-3.81M38.32%-3.22M71.94%-1.48M-16.74%-4.81M-51.32%-20.28M-36.17%-5.66M
Income tax
Net income 10.72%-2.87M-98.38%-2.94M32.13%-3.26M34.32%-13.32M32.66%-3.81M38.32%-3.22M71.94%-1.48M-16.74%-4.81M-51.32%-20.28M-36.17%-5.66M
Net income continuous Operations 10.72%-2.87M-98.38%-2.94M32.13%-3.26M34.32%-13.32M32.66%-3.81M38.32%-3.22M71.94%-1.48M-16.74%-4.81M-51.32%-20.28M-36.17%-5.66M
Minority interest income
Net income attributable to the parent company 10.72%-2.87M-98.38%-2.94M32.13%-3.26M34.32%-13.32M32.66%-3.81M38.32%-3.22M71.94%-1.48M-16.74%-4.81M-51.32%-20.28M-36.17%-5.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.72%-2.87M-98.38%-2.94M32.13%-3.26M34.32%-13.32M32.66%-3.81M38.32%-3.22M71.94%-1.48M-16.74%-4.81M-51.32%-20.28M-36.17%-5.66M
Basic earnings per share 63.00%-0.3723.73%-0.4563.77%-0.7563.39%-4.2470.34%-0.764.91%-183.43%-0.5927.37%-2.0730.45%-11.5841.73%-2.36
Diluted earnings per share 63.00%-0.37-20.34%-0.7163.77%-0.7563.39%-4.2470.34%-0.764.91%-183.43%-0.5927.37%-2.0730.45%-11.5841.73%-2.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data